Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures

被引:4
|
作者
Huo, Chen [1 ]
Zhang, Meng-Yu [1 ]
Li, Rui [1 ]
Liu, Ting-Ting [1 ]
Li, Jian-Ping [1 ]
Qu, Yi-Qing [2 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Pulm & Crit Care Med,Shandong Key Lab Infect, Jinan, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pulm & Crit Care Med, Shandong Key Lab Infect Resp Dis, Jinan, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
关键词
lung adenocarcinoma; glycolysis; tumor mutational burdens; prognosis; tumor-infiltrating immune cell; INTERACTION NETWORKS; CANCER; TUMORS; INHIBITION; RESISTANCE;
D O I
10.3389/fcell.2021.645482
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in large LUAD samples were collected from the Cancer Genome Atlas (TCGA) database. Then, we identified the expression level and prognostic value of glycolysis-related genes, as well as the fractions of 22 immune cells in the tumor microenvironment. The differences between glycolysis activity, mutation, and immune infiltrates were discussed in these groups, respectively. Two hundred fifty-five glycolysis-related genes were identified from gene set enrichment analysis (GSEA), of which 43 genes had prognostic values (p < 0.05). Next, we constructed a glycolysis-related competing endogenous RNA (ceRNA) network which related to the survival of LUAD. Then, two subgroups of LUAD (clusters 1 and 2) were identified by applying unsupervised consensus clustering to 43 glycolysis-related genes. The survival analysis showed that the cluster 1 patients had a worse prognosis (p < 0.001), and upregulated differentially expressed genes (DEGs) are interestingly enriched in malignancy-related biological processes. The differences between the two subgroups are SPTA1, KEAP1, USH2A, and KRAS among top 10 mutated signatures, which may be the underlying mechanism of grouping. Combined high tumor mutational burden (TMB) with tumor subgroups preferably predicts the prognosis of LUAD patients. The CIBERSORT algorithm results revealed that low TMB samples were concerned with increased infiltration level of memory resting CD4+ T cell (p = 0.03), resting mast cells (p = 0.044), and neutrophils (p = 0.002) in cluster 1 and high TMB samples were concerned with increased infiltration level of memory B cells, plasma cells, CD4 memory-activated T cells, macrophages M1, and activated mast cells in cluster 2, while reduced infiltration of monocytes, resting dendritic cells, and resting mast cells was captured in cluster 2. In conclusion, significant different gene expression characteristics were pooled according to the two subgroups of LUAD. The combination of subgroups, TMB and tumor-infiltrating immune cell signature, might be a novel prognostic biomarker in LUAD.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] DCUN1D5 is a prognostic biomarker and correlated immune infiltrates and glycolysis in lung adenocarcinoma
    Zhao, Song
    Han, Xiaoli
    Huang, Jingtao
    Zheng, Jingxiong
    Zhao, Baoshan
    Liang, Zongying
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [22] Development and preliminary validation of five miRNAs for lung adenocarcinoma prognostic model associated with immune infiltration
    Yang, Huanzhang
    Hua, Jingli
    Han, Yanxia
    Chang, Dong
    Zheng, Wenlong
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [23] Identification of a coagulation-related signature correlated with immune infiltration and their prognostic implications in lung adenocarcinoma
    Yang, Siqian
    Chen, Shiqi
    Zhao, Yue
    Wu, Tao
    Wang, Yuquan
    Li, Tingting
    Fu, Liwan
    Ye, Ting
    Hu, Yue-Qing
    Chen, Haiquan
    THORACIC CANCER, 2023, 14 (33) : 3295 - 3308
  • [24] Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma
    Yin, Xiang-Qian
    Yin, Xue-Hui
    Yu, Ya-Qin
    Xu, Lang
    Zhang, Mao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma
    Jiang, Yingfeng
    Yu, Lili
    Hu, Qingfeng
    Kang, Yanli
    You, Jianbin
    Huang, Chen
    Xu, Xunyu
    Chen, Liangyuan
    MOLECULAR IMMUNOLOGY, 2023, 153 : 226 - 237
  • [26] ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma
    Yang, Wendi
    Chen, Kehong
    Yu, Qian
    Liao, Rongxin
    He, Hengqiu
    Peng, Yuan
    Yang, Zhenzhou
    Zhang, Xiaoyue
    CANCER MEDICINE, 2023, 12 (13): : 14820 - 14832
  • [27] Differential Infiltration of Immune Cells Driven by Tumor Heterogeneity Reveals Two Immune Subtypes in Lung Adenocarcinoma
    Wang, Liqiang
    Song, Ying
    Bai, Jing
    Sun, Wenjing
    Yu, Jingcui
    Cai, Mengdi
    Fu, Songbin
    FRONTIERS IN GENETICS, 2022, 13
  • [28] CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma
    Jia, Erna
    Shi, Xianquan
    Xue, Jinru
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (03) : 1241 - 1251
  • [29] GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
    Song, Shimao
    Deng, Xinzhou
    Jiang, Shan
    Tian, Chao
    Han, Jiahui
    Chai, Jingjing
    Li, Na
    Yan, Yutao
    Luo, Zhiguo
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (11)
  • [30] Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma
    Wang, Yuzhi
    Huang, Xiaoxiao
    Fan, Hong
    Xu, Yunfei
    Qi, Zelin
    Zhang, Yi
    Huang, Yi
    AGING-US, 2023, 15 (10): : 4202 - 4235